WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS

Antiseptic and antiinfective preparations for systemic use specifically used in urinary tract infections, see J01.
Antiinfectives for systemic use, see group J.
Gynecological antiinfectives and antiseptics, see G01.


G04B UROLOGICALS

This group comprises urological preparations other than antiseptics and antiinfectives.


G04BE Drugs used in erectile dysfunction

Alprostadil intracavernosal injection for treatment of erectil dysfunction is classified here, while formulations used to maintain the patency of the ductus arteriosis in neonates are classified in C01EA01.
Combinations of papaverine and phentolamine for intracavernous administration are classified under G04BE30 - combinations. Combinations of phentolamine and aviptadil (polypeptide) are classified under G04BE30 - combinations.
Phosphodisesterase inhibitors also indicated for pulmonary arterial hypertension (PAH) are classified in this group. Other agents used for treatment of PAH are classified in C02KX or in B01AC. Combinations of ambrisentan or macitentan and phosphodisesterase inhibitors are classified in C02KX - Antihypertensives for pulmonary arterial hypertension.
Combinations of alpha-adrenoreceptor antagonists or testosterone-5-alpha reductase inhibitors and phosphodisesterase inhibitors used in benign prostatic hypertrophy are classified in G04CA or G04CB, respectively.

The DDDs are based on single treatment of erectile dysfunction.


    ATC code  Name  DDD  U Adm.R Note
    G04BE01 alprostadil 20 mcg 
    0.25 mg urethral 

List of abbreviations

Last updated: 2024-01-26